HeartBeam raises ~$1.4M in registered direct offering of 1M shares at $1.50/sh

HeartBeam, Inc.

Sold 1,000,000 shares of common stock at $1.50/share to an accredited investor.
Net proceeds after fees and expenses approximately $1.4 million.
Engaged A.G.P./Alliance Global Partners as financial advisor for $70,000 fixed fee.
Offering conducted via shelf registration statement on Form S-3 (File No. 333-269520).

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

HeartBeam, Inc. entered into Financial Advisory Agreement with A.G.P./Alliance Global Partners valued at fixed sum of $70,000 (effective 2023-04-27).

Action: entry
Counterparty: A.G.P./Alliance Global Partners
Value: fixed sum of $70,000
Effective: 2023-04-27

Exact text from the filing

on April 27, 2023, the Company entered into a Financial Advisory Agreement (the “ Financial Advisory Agreement ”) with A.G.P./Alliance Global Partners

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

HeartBeam, Inc. entered into Securities Purchase Agreement with an accredited investor valued at 1,000,000 shares of common stock at a price of $1.50 per share, generating net proceeds of approxima (effective 2023-05-02).

Action: entry
Agreement: equity purchase
Counterparty: an accredited investor
Value: 1,000,000 shares of common stock at a price of $1.50 per share, generating net proceeds of approxima
Effective: 2023-05-02

Exact text from the filing

On May 2, 2023, HeartBeam, Inc. (the “ Company ”) entered into a Securities Purchase Agreement (the “ SPA ”) with an accredited investor

View on SEC.gov

Browse all material agreements →

HeartBeam, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-23-036932

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.